Years After Promise of Stem Cells Seemed to Be Fading, Clinical Trials Underway
November 1, 2018
(Milwaukee Journal Sentinel) – In January 2007, nine years after James Thomson’s discovery, a gloom about human embryonic stem cells had begun to set in, epitomized by a New York Times headline: “Concerns of Dashed Hopes From Promised Miracles.” Today, a little more than a decade later, the gloom appears to be lifting. Mature cells developed from the embryonic lines Thomson grew as an assistant scientist at the University of Wisconsin-Madison have been implanted in humans — the first real wave of clinical trials. Thomson now works as director of regenerative biology at the Morgridge Institute for Research in Madison.